LncRNA H19 aggravates TNF-α-induced inflammatory injury via TAK1 pathway in MH7A cells

Biofactors. 2020 Sep;46(5):813-820. doi: 10.1002/biof.1659. Epub 2020 Jun 11.

Abstract

Rheumatoid arthritis (RA) is a common chronic autoimmune disease in women. This research aims to disclose the probable function of lncRNA H19 in MH7A cells. The influences of tumor necrosis factor-α (TNF-α) on cell viability, apoptosis, and inflammatory factor expression were, respectively, detected through cell counting kit-8 (CCK-8), flow cytometry, quantitative reverse transcription polymerase chain reaction (qRT-PCR), enzyme-linked immunosorbent assay (ELISA) assay and Western Blot. The levels of H19 and TAK1 were, respectively, tested through qRT-PCR and Western blot. The expression of NF-κB and JNK/p38MAPK pathway-associated proteins was tested through Western blot. We found that TNF-α reduced MH7A cell viability in a concentration-dependent manner and facilitated apoptosis and IL-8, IL-1β, and IL-6 production. Besides, TNF-α treatment raised the level of H19 in MH7A cells. Moreover, H19 silence reduced the levels of inflammatory cytokines, while overexpression of H19 reversed this effect. TNF-α treatment elevated the expression of inflammatory cytokines by up-regulating H19. Furthermore, overexpression of H19 promoted TAK1 phosphorylation. Following studies revealed that H19 activated NF-κB and JNK/p38 MAPK pathways by promoting TAK1 phosphorylation.

Keywords: JNK/p38MAPK pathway; LncRNA H19; NF-κB pathway; TAK1; TNF-α; rheumatoid arthritis.

MeSH terms

  • Apoptosis / drug effects
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / genetics
  • Arthritis, Rheumatoid / pathology
  • Cell Proliferation / drug effects
  • Gene Expression Regulation / drug effects
  • Humans
  • Inflammation / drug therapy*
  • Inflammation / genetics
  • Inflammation / pathology
  • Interleukin-1beta / genetics
  • MAP Kinase Kinase Kinases / genetics*
  • MAP Kinase Signaling System / drug effects
  • NF-kappa B / genetics
  • Phosphorylation / drug effects
  • RNA, Long Noncoding / antagonists & inhibitors
  • RNA, Long Noncoding / genetics*
  • Signal Transduction / drug effects
  • Transcription Factor RelA / genetics
  • Transcription Factor RelA / pharmacology*
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / pharmacology
  • p38 Mitogen-Activated Protein Kinases / genetics

Substances

  • H19 long non-coding RNA
  • IL1B protein, human
  • Interleukin-1beta
  • NF-kappa B
  • RELA protein, human
  • RNA, Long Noncoding
  • Transcription Factor RelA
  • Tumor Necrosis Factor-alpha
  • p38 Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase Kinases
  • MAP kinase kinase kinase 7